A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial.
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2014
At a glance
- Drugs Docetaxel (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PROSTY
- 31 Aug 2018 Biomarkers information updated
- 01 Feb 2014 Results of a QOL analysis presented at the 2014 Genitourinary Cancers Symposium.
- 07 Jun 2011 Final analysis results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History